INS and diabetes mellitus: Interestingly, broad pharmacological inhibition of these isomerases with, e.g., the potent immunosuppressant FK506, deteriorates insulin mRNA levels, glucose-stimulated insulin secretion, β-cell survival and leads to diabetes development in immunosuppressed patients post transplantation [15,16,17,18,19].